Literature DB >> 21292634

Characterization of the methylation patterns in human papillomavirus type 16 viral DNA in head and neck cancers.

Il-Seok Park1, Xiaofei Chang, Myriam Loyo, Gaosong Wu, Alice Chuang, Myoung Sook Kim, Young Kwang Chae, Sofia Lyford-Pike, William H Westra, John R Saunders, David Sidransky, Sara Isabel Pai.   

Abstract

Human papillomavirus (HPV) type 16 can integrate into the host genome, thereby rendering the viral coding genes susceptible to epigenetic modification. Using bisulfite genomic sequencing, we determined the methylation status of all 110 CpG sites within the viral epigenome in advanced stage III/IV HPV-16-associated head and neck cancers. We found that the viral genome was hypomethylated in the majority of head and neck cancers, in particular within the viral regulatory region, long control region (LCR), which controls transcription of the E6 and E7 oncogenes. The hypomethylation status of LCR correlated with detectable levels of E6 and E7 expression, which suggests that the tumors may still be dependent on these viral oncogenes to maintain the malignant phenotype. In addition to the methylation status of LCR, we report other potential factors which may influence intratumoral E6 and E7 expression including viral copy number and integration site. We were able to detect the viral epigenetic alterations in sampled body fluids, such as serum and saliva, which correlated with the changes observed in the primary tumors. Because viral epigenetic changes occur in the setting of viral integration into the human genome, the detection of methylated HPV genes in the serum and/or saliva may have diagnostic potential for early detection strategies of viral integration and assessment of risk for cancer development in high-risk individuals. Our findings also support continued targeting of the E6 and/or E7 antigens through various vaccine strategies against HPV-associated cancers. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292634      PMCID: PMC3079312          DOI: 10.1158/1940-6207.CAPR-10-0147

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  34 in total

1.  The role of DNA methylation in mammalian epigenetics.

Authors:  P A Jones; D Takai
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

2.  Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18.

Authors:  A Garcia-Carranca; F Thierry; M Yaniv
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells.

Authors:  E Schwarz; U K Freese; L Gissmann; W Mayer; B Roggenbuck; A Stremlau; H zur Hausen
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

4.  Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.

Authors:  T Chong; W K Chan; H U Bernard
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

Review 5.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

Review 6.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

7.  Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites.

Authors:  E C Thorland; S L Myers; D H Persing; G Sarkar; R M McGovern; B S Gostout; D I Smith
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

8.  Clonal selection for transcriptionally active viral oncogenes during progression to cancer.

Authors:  Brian A Van Tine; John C Kappes; N Sanjib Banerjee; Judith Knops; Lilin Lai; Renske D M Steenbergen; Chris L J M Meijer; Peter J F Snijders; Pamela Chatis; Thomas R Broker; Phillip T Moen; Louise T Chow
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes.

Authors:  Benyue Zhang; R Nicholas Laribee; Michael J Klemsz; Ann Roman
Journal:  Virology       Date:  2004-11-10       Impact factor: 3.616

10.  CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression.

Authors:  Vinay Badal; Linda S H Chuang; Eileen Hwee-Hong Tan; Sushma Badal; Luisa L Villa; Cosette M Wheeler; Benjamin F L Li; Hans-Ulrich Bernard
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  23 in total

1.  Cervical cancer pathogenesis is associated with one-carbon metabolism.

Authors:  Sujata Pathak; Neerja Bhatla; Neeta Singh
Journal:  Mol Cell Biochem       Date:  2012-06-23       Impact factor: 3.396

Review 2.  Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis.

Authors:  Jason Brocato; Max Costa
Journal:  Crit Rev Toxicol       Date:  2013-07       Impact factor: 5.635

3.  Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.

Authors:  Takashi Hatano; Daisuke Sano; Hideaki Takahashi; Hiroshi Hyakusoku; Yasuhiro Isono; Shoko Shimada; Kae Sawakuma; Kentaro Takada; Ritsuko Oikawa; Yoshiyuki Watanabe; Hiroyuki Yamamoto; Fumio Itoh; Jeffrey N Myers; Nobuhiko Oridate
Journal:  Int J Cancer       Date:  2017-01-09       Impact factor: 7.396

4.  Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell Carcinoma.

Authors:  Laura S Rozek; Shama Virani; Emily L Bellile; Jeremy M G Taylor; Maureen A Sartor; Katie R Zarins; A Virani; C Cote; Francis P Worden; Mark E Prince Mark; Scott A McLean; Sonya A Duffy; George H Yoo; Nabil F Saba; Dong M Shin; Omer Kucuk; Gregory T Wolf
Journal:  Nutr Cancer       Date:  2019-03-12       Impact factor: 2.900

5.  Lack of methylation in the upstream region of human papillomavirus type 6 from aerodigestive tract papillomas.

Authors:  Agustín Enrique Ure; Ola Forslund
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 6.  Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.

Authors:  Megan A Clarke; Nicolas Wentzensen; Lisa Mirabello; Arpita Ghosh; Sholom Wacholder; Ariana Harari; Attila Lorincz; Mark Schiffman; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

7.  APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers.

Authors:  S Kondo; K Wakae; N Wakisaka; Y Nakanishi; K Ishikawa; T Komori; M Moriyama-Kita; K Endo; S Murono; Z Wang; K Kitamura; T Nishiyama; K Yamaguchi; S Shigenobu; M Muramatsu; T Yoshizaki
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

Review 8.  Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.

Authors:  Robbie Woods; Esther M O'Regan; Susan Kennedy; Cara Martin; John J O'Leary; Conrad Timon
Journal:  World J Clin Cases       Date:  2014-06-16       Impact factor: 1.337

9.  Human Papillomavirus Type 16 L2 DNA Methylation in Exfoliated Cervical Cells From College-Age Women.

Authors:  Erin L Anderson; Carolyn E Banister; Susannah Kassler; Amy Messersmith; Lucia Pirisi; Kim E Creek; Michael D Wyatt
Journal:  J Low Genit Tract Dis       Date:  2016-10       Impact factor: 1.925

10.  Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapy.

Authors:  Jessica Hier; Olivia Vachon; Allison Bernstein; Iman Ibrahim; Alex Mlynarek; Michael Hier; Moulay A Alaoui-Jamali; Mariana Maschietto; Sabrina Daniela da Silva
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.